Navigation Links
Panel suggests selling allergy drugs OTC

An advisory committee to the U.S. Food and Drug Administration recommended that three popular allergy drugs are safe enough to be used without a prescription. The FDA does not have to follow the advice of its advisory committee, though it usually does. There is no deadline for making a decision. //

"Drugs are prescription for a reason. They have the ability to do both good and harm. Claritin, Allegra and Zyrtec have almost no side effects and are equally effective as the antihistamines that are available over the counter today." said Robert Seidman, WellPoint's chief pharmacy officer.

Anti-allergy medications have been linked to side effects in some users that include reduced alertness, nausea and headache. By prescription, the drugs cost about $80 per month versus $10 to $15 in the 17 nations where the drugs are over-the-counter. The drug makers oppose a switch, which would cost them money.

Usually, drug companies support making a drug over-the-counter only when their patent is about to run out, because doing so at that time extends the period during which makers of generic drugs are prohibited from selling lower-priced versions of the drug.

Claritin's patent is due to expire in 2002, but the company is waging a multi-million-dollar campaign to get it extended. Aventis Pharmaceuticals, which manufactures Allegra, also expressed its disappointment. According to WellPoint, sales of Allegra, Claritin and Zyrtec exceeded $5 billion last year.
'"/>




Page: 1

Related medicine news :

1. Anti-Quota Stir: Resident Docs Demand Experts Panel
2. Circumcision Studies to Continue Says Health Panel
3. Panel to Help Combat HIV/AIDS In Asia-Pacific Region
4. Breast Cancer Review Panel Adds Two Experts
5. Shingles Vaccine For Older People - Panel Recommendation
6. Complaints Against US Federal lab Over-ruled by Panel
7. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
8. Generic Biologics – U.S Panel Hearing Draws Mixed Response
9. Expert Panel Sets Limits on Pesticide Residues in Soft Drinks
10. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
11. National Pharmaceutical Policy Referred to Ministerial Panel
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... Tim ... program serving families of greater Dubuque, IA. The current campaign fundraises for Veteran’s ... discharged veterans. Donations to Veteran’s Freedom Center may now be made here: ...
(Date:5/5/2016)... ... 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC ... Stong is double board certified and the only facial plastic surgeon in Atlanta to ... Non-surgical therapies such as stem cells can be used to provide stabilization to hair ...
(Date:5/5/2016)... , ... (PRWEB) May 05, 2016 , ... Talent ... acquisition startup, HireNurses, on the eve of National Nurses Week (May 6-12). ... and healthcare employers. With their enrollment into the Talent Tech Lab Virtual Incubation program, ...
(Date:5/5/2016)... ... May 05, 2016 , ... VisualDx ... Android devices. VisualDx is the first point of care diagnostic support system ... medicine. The system speeds diagnosis, therapy decisions and patient education for emergency ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS ... to announce its new referral program, giving participants incentive for spreading the word ... community, and we know many professionals share resources with their friends and colleagues,” ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... PUNE, India , May 4, 2016 /PRNewswire/ ... report spreads across 154 pages, profiling 09 key ... It is a professional and in-depth study on ... providing a basic overview of the industry including ... Insulin Needles market analysis is provided for the ...
(Date:5/3/2016)... 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: